Skip to content
DataLookout
Menu

NCT07071415

Overdiagnosis and Breast Cancer Screening Decisions

StatusCompleted
PhaseNot applicable
Primary completion
Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 5 versions: 5 with changes below. See every version on ClinicalTrials.gov ↗

  1. Notable Results posted: Nov 9, 2026 Show 4 more changesShow less
    • Eligibility criteria expanded, about 3 words
    • Enrollment target: 308 to 307
    • Secondary endpoints revised (2)
    • Primary endpoint revised
  2. Minor Enrollment target: 311 to 308v4
  3. Minor Trial status: Recruiting to Completedv3 Show 4 more changesShow less
    • Enrollment target: estimated 300 to confirmed 311
    • Primary and study completion dates changed from estimate of Aug 2025 to Oct 20, 2025
    • Start date: Jul 23, 2025 to Aug 19, 2025
    • Site details revised
  4. Notable Trial status: Not Yet Recruiting to Recruiting
    • Start date changed from estimate of Jul 2025 to Jul 23, 2025
    • Site details revised
    v2
  5. Study First Submitted
  • Notable: the plan changed
  • Minor: routine updates

Endpoints

Primary

Participants Intention to Screen
Timeframe: Day 1

Secondary (2)

Knowledge of Breast Cancer Screening
Understanding of Overdiagnosis

Arms and interventions

Low risk of overdiagnosisExperimental

Participants in this arm will be shown a decision aid in which risk of overdiagnosis is low.

Moderate risk of overdiagnosisExperimental

Participants in this arm will be shown a decision aid in which risk of overdiagnosis is moderate.

High risk of overdiagnosisExperimental

Participants in this arm will be shown a decision aid in which risk of overdiagnosis is high.

ControlActive comparator

Participants in this arm will be shown a video about breast cancer screening that is identical in all ways but contains no information about overdiagnosis.

Behavioral: Breast cancer screening decision aid -- low risk, Breast cancer decision aid -- moderate risk, Breast cancer screening decision aid -- high risk

Other: Control condition

Sites

1 site in 1 country

  • Yale School of MedicineNew Haven, Connecticut, United States